- Home
- LCTX vs SPCE Comparison
LCTX vs SPCE Comparison
Compare LCTX & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCTX
- SPCE
- Stock Information
- Founded
- LCTX 1990
- SPCE 2017
- Country
- LCTX United States
- SPCE United States
- Employees
- LCTX N/A
- SPCE N/A
- Industry
- LCTX Biotechnology: Biological Products (No Diagnostic Substances)
- SPCE Transportation Services
- Sector
- LCTX Health Care
- SPCE Consumer Discretionary
- Exchange
- LCTX Nasdaq
- SPCE Nasdaq
- Market Cap
- LCTX 165.6M
- SPCE 166.3M
- IPO Year
- LCTX N/A
- SPCE N/A
- Fundamental
- Price
- LCTX $0.92
- SPCE $6.96
- Analyst Decision
- LCTX Strong Buy
- SPCE Hold
- Analyst Count
- LCTX 3
- SPCE 6
- Target Price
- LCTX $5.67
- SPCE $26.50
- AVG Volume (30 Days)
- LCTX 307.7K
- SPCE 1.2M
- Earning Date
- LCTX 11-07-2024
- SPCE 11-06-2024
- Dividend Yield
- LCTX N/A
- SPCE N/A
- EPS Growth
- LCTX N/A
- SPCE N/A
- EPS
- LCTX N/A
- SPCE N/A
- Revenue
- LCTX $6,186,000.00
- SPCE $10,742,000.00
- Revenue This Year
- LCTX N/A
- SPCE N/A
- Revenue Next Year
- LCTX $119.00
- SPCE N/A
- P/E Ratio
- LCTX N/A
- SPCE N/A
- Revenue Growth
- LCTX N/A
- SPCE 175.51
- 52 Week Low
- LCTX $0.77
- SPCE $5.27
- 52 Week High
- LCTX $1.61
- SPCE $54.60
- Technical
- Relative Strength Index (RSI)
- LCTX 52.69
- SPCE 54.18
- Support Level
- LCTX $0.83
- SPCE $5.75
- Resistance Level
- LCTX $0.94
- SPCE $7.23
- Average True Range (ATR)
- LCTX 0.05
- SPCE 0.42
- MACD
- LCTX 0.01
- SPCE 0.14
- Stochastic Oscillator
- LCTX 81.09
- SPCE 81.93
About LCTX Lineage Cell Therapeutics Inc.
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cells transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.